Preparing for Tuberculosis Vaccine M72/AS01E Implementation
This correction relates to the global demand forecast for the potential implementation of the M72/AS01E TB vaccine
FInancing strategies
Insights on the implementation strategies for a potential new tuberculosis vaccine in South Africa
Examines how a potential new TB vaccine could be introduced in South Africa. Interviews with 26 stakeholders explored implementation priorities, target populations, vaccine price, cost-effectiveness, regulatory approval, financing, procurement, delivery logistics, vaccine acceptability and lessons from existing vaccination programmes.
Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa
The workshop aimed to align stakeholders on priority populations and delivery strategies for future TB vaccines, identify evidence needs to inform national policy decision-making, and outline actions required to ensure timely and equitable introduction.
Protecting investment in TB vaccine R&D and health systems amid debt distress and reform
IMF analysis reveals 51 countries with moderate-to-high risk of sovereign debt distress
and 9 countries in debt distress: unable to fulfill financial obligations to lenders. For many high-TB burden countries, yearly debt servicing now exceeds domestic revenue – forcing countries to cut
expenditure on health. Based on a literature review and engagement with World Bank/IMF, this
abstract presents a policy analysis of the implications of sovereign debt distress on TB vaccine
readiness and proposes debt relief and reform as innovative financial tools for creating fiscal space
for government investment in vaccine R&D and implementation
IAVI
1. Understand likely use cases, delivery strategies, target populations, and drivers of preference and adoption; 2. Project demand; 3. Evaluate potential willingness to pay and budget impact; 4. Explore innovative financing mechanisms;
Conducting market analyses for new tuberculosis vaccines for adolescents and adults: A summary of one approach applied to M72/AS01E
A summary report of the methodology used in the MM Global Health Consulting (MMGH) market analysis and the high-level findings and recommendations.